This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Mark Your Calendar for Next Year's Event!
May 9-12, 2022Hynes Convention Center, Boston

Patrick Knerr, Ph.D.
Principal Scientist at Novo Nordisk Research Center Indianapoli


Patrick J. Knerr obtained his BS in Biochemistry from the University of Delaware and his PhD in Chemistry from the University of Illinois Urbana-Champaign. He joined the Novo Nordisk Research Center in Indianapolis, IN, in 2016 as a peptide medicinal chemist. His research focuses on peptide-based drug discovery for metabolic and rare endocrine diseases, with particular interest in proglucagon-derived metabolic hormones.

Agenda Sessions

  • ROOM 205B: Discovery and Optimization of Long-acting, Unimolecular Peptide Triple Agonists of the GLP-1, GIP, and Glucagon Receptors